Economic Burden and Cost Differences Between Branded and Generic Topical Antifungals in India
Prateek DT, Kavitha Dongerkery, Pradnya Deolekar, Atharva Dahibhate, SriramBabu V, Safaa Mohammed Shahid, Arjun Ananthanarayan, Nidhi H Vadhavekar · 2026
Read Economic Burden and Cost Differences Between Branded and Generic Topical Antifungals in India by Prateek DT, Kavitha Dongerkery, Pradnya Deolekar, Atharva Dahibhate, SriramBabu V, Safaa Mohammed Shahid, Arjun Ananthanarayan, Nidhi H Vadhavekar (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13396423.txt.
Description
Prateek D. T. and co-authors compared the prices of branded and generic creams for skin fungal infections in India, in a 2026 pharmacoeconomic study. These infections, called superficial mycoses, are common in tropical climates, need long treatment, and often return, so the price of each tube matters to households.
The authors gathered prices for the same antifungal drugs across many brands and measured the spread between the cheapest generic and the costliest branded twin. Wide gaps for identical medicine mean doctors can cut a patient's bill sharply by prescribing choice alone. The study frames antifungal pricing as a resource question for clinics as much as a shopping question for patients.
Catalog record
| CREATOR | Prateek DT, Kavitha Dongerkery, Pradnya Deolekar, Atharva Dahibhate, SriramBabu V, Safaa Mohammed Shahid, Arjun Ananthanarayan, Nidhi H Vadhavekar |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32564 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |